Institutional investors hold a majority ownership of LLY through the 65.76% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2014, these large investors purchased a net $3.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 7.4 Million shares of Eli Lilly and Co
FIL INVESTMENTS INTERNATIONAL Bought 3.1 Million shares of Eli Lilly and Co
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.8 Million shares of Eli Lilly and Co